BIOGEN Financials

Please note, the presentation of BIOGEN's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BIOGEN's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BIOGEN's management manipulating its earnings.

BIOGEN's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BIOGEN volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on BIOGEN INC 52 correlated with the market. If Beta is less than 0 BIOGEN generally moves in the opposite direction as compared to the market. If BIOGEN Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BIOGEN INC 52 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BIOGEN is generally in the same direction as the market. If Beta > 1 BIOGEN moves generally in the same direction as, but more than the movement of the benchmark.